Two doctors named BMS Korea’s medical directors

Recently, BMS Korea appointed two doctors, Lee Young-sook and Chung Young-yeon, as medical director and medical advisor, respectively, to beef up its marketing activity of Baraclude (entecavir), an antiviral agent for treatment of chronic hepatitis B virus, which was launched in January.

A graduate of Pusan National University Medical College, Lee was trained at the US-based University of Ca...